Heinrich, Kathrin
Miller-Phillips, Lisa
Ziemann, Frank
Hasselmann, Korbinian
Rühlmann, Katharina
Flach, Madeleine
Biro, Dorottya
von Bergwelt-Baildon, Michael
Holch, Julian
Herold, Tobias
von Baumgarten, Louisa
Greif, Philipp A. http://orcid.org/0000-0002-3744-7936
Jeremias, Irmela
Wuerstlein, Rachel
Casuscelli, Jozefina
Spitzweg, Christine
Seidensticker, Max
Renz, Bernhard
Corradini, Stefanie
Baumeister, Philipp
Goni, Elisabetta
Tufman, Amanda
Jung, Andreas
Kumbrink, Jörg
Kirchner, Thomas
Klauschen, Frederick
Metzeler, Klaus H.
Heinemann, Volker
Westphalen, C. Benedikt http://orcid.org/0000-0002-5310-3754
Funding for this research was provided by:
Universitätsklinik München
Article History
Received: 24 March 2022
Accepted: 18 June 2022
First Online: 7 July 2022
Change Date: 6 August 2022
Change Type: Update
Change Details: The original article is updated to correct the spelling of first name of the author (Philip A. Greif) as “Philipp” and also for including his ORCID
Declarations
:
: Kathrin Heinrich: Honoraria: Roche, Consulting or Advisory Role: Servier, Travel, Accommodations, Expenses: Lilly, AMGEN, Celgene. Lisa Miller-Phillips: reimbursement for travel by Merck. Michael von Bergwelt-Baildon: honoraria, research funding and speakers bureau: MSD Sharp & Dohme, Novartis, Roche, KITE/Gilead, Bristol-Myers Squibb, Astellas, Mologen, Miltenyi. Julian Holch: Advisory Role: Roche, Honoraria: Roche, Travel Support: Novartis. Philipp A. Greif: Astra Zeneca: Medical Advisory Board 2020. Rachel Würstlein: Served as advisor, consultant, speaker and travel grant: Agendia, Amgen, Aristo, Astra Zeneca, Boeringer Ingelheim, Carl Zeiss, Celgene, Clinsol, Daiichi-Sankyo, Eisai, ExactSciences, Genomic Health, Gilead, Glaxo Smith Kline, Hexal, Lilly, Medstrom Medical, MSC, Mundipharma, Nanostrin, Novartis, Odonate. Christine Spitzweg: Honoraria for lectures or advisory board: Lilly, Roche, Eisai, Ipsen, Bayer, Blueprint Medicine. Max Seidensticker: grants and personal fees from Sirtex, Bayer Healthcare, personal fees from Siemens, Cook, Boston Scientific, Astra Zeneca. Stefanie Corradini: honoraria or travel/accommodation expenses: Elekta, Brainlab, Viewray, C-RAD, Roche, research funding: Elekta, Brainlab, Viewray. Andreas Jung: Consulting or advisory role: Amgen, AstraZeneca, BIocartis, Novartis; Speakers’ Bureau: Amgen, AstraZeneca, Bayer Pharmaceuticals, Biocartis, BMS, Boehringer Ingelheim, Merck KgA, Lilly, MSD, Novartis, Qiagen, QuIP GmbH, Roche Pharma, Takeda, Thermo Fisher; Travel/Accommodation/Expenses: Amgen, AstraZeneca, Bayer Pharmaceuticals, Biocartis, BMS, Boehringer Ingelheim, Merck KgA, Lilly, MSD, Novartis, Qiagen, QuIP GmbH, Roche Pharma, Takeda, Thermo Fisher. Jörg Kumbrink: received honoraria and reimbursement for travel and accommodation for participants in advisory boards from AstraZeneca, Novartis, and Roche Pharma. Thomas Kirchner: Consulting/Advisory: Amgen, AstraZeneca, Bayer, BMS, Boehringer Ingelheim, Merck KGaA, MSD, Novartis, Pfizer, Qiagen, Roche, Takeda; Research Funding: Merck, Roche; Speaker: Merck, Astra Zeneca. Frederick Klauschen: Co-Founder AI-BIH/Charité-Spinoff Aignostics GmbH; Advisor BMS, Novartis, Roche, Lilly, Agilent, AstraZeneca and Merck. Klaus Metzeler: Beratertätigkeit: Celgene/BMS, Novartis, Jazz Pharmaceuticals, Pfizer; Honorare: Celgene/BMS, Daiichi Sankyo, Astellas, AbbVie, Novartis, Janssen; Finanzierung wissenschaftlicher Untersuchungen: Celgene. Volker Heinemann: Honoraria: Merck, Roche, Celgene, AMGEN, Sanofi, Lilly, SIRTEX, Boehringer-Ingelheim, Taiho, Servier; Consulting or Advisory Board: Merck, Roche, AMGEN, Sanofi, SIRTEX, Servier, Celgene, Boehringer-Ingelheim, Halozyme, MSD, BMS; Research funding: MERCK, Roche, AMGEN, SIRTEX, Servier, Celgene, Boehringer-Ingelheim, Shire; Travel Accommodation expenses: MERCK, Roche, AMGEN, SIRTEX, Servier, Shire, MSD, BMS. Christoph Benedikt Westphalen: has received honoraria from Bayer, Celgene, Ipsen, F. Hoffmann-La Roche Ltd, Servier, and Taiho, served in a consulting/advisory role for BMS, Celgene, Merck, Shire/Baxalta, Rafael Pharmaceuticals, RedHill BioPharma, and F. Hoffmann-La Roche Ltd, has received travel/accommodation expenses from Bayer, Celgene, RedHill BioPharma, F. Hoffmann-La Roche Ltd, Servier, and Taiho and has received research funding from F. Hoffmann-La Roche Ltd.. Frank Ziemann, Korbinian Hasselmann, Katharina Rühlmann, Madeleine Flach, Dorottya Biro, Tobias Herold, Louisa von Baumgarten, Irmela Jeremias, Bernhard Renz, Philipp Baumeister, Elisabetta Goni: none declared. Jozefina Casuscelli, Amanda Tufman: no information.
: Patients were included in a clinical registry that allowed for retrospective analyses of clinical and molecular anonymized data.